Key Takeaways
- Strong headline growth, but US softens: Constant-currency revenue grew +17.5% YoY, yet the US, its largest market, declined sequentially as a deliberate diversification strategy and a large program ended without renewal.
- GenAI unit swings to profit: The Generative AI business unit broke even at the operating level this quarter, swinging from a loss of ~₹2.53 crores to a marginal profit, with utilization jumping from 34.3% to 40.8%.
- Margins held despite investment intensity: EBITDA margin held at 21.4% for the 20th consecutive quarter, while operating margin rebounded 19.7% sequentially to 17.6%, even as the company continued investing in its GenAI unit and a new sales engine.
- Headcount declined while revenue grew: Headcount fell both QoQ and YoY, a deliberate divergence management attributes to just-in-time hiring and repurposing people across projects rather than linear addition.
- What to watch next quarter: Whether wage hikes compress margins as warned, whether the TME momentum from the cinema chain deal actually rolls into Q2 and Q3, and whether the US revenue decline stabilizes or deepens.
Growth Drivers & Vertical Performance
- Transformational initiatives bearing fruit: 10 initiatives launched over the past two years are now delivering tangible results, with the reorganization into six industry verticals in H2 FY25 fuelling accelerated growth in Travel, Media & Entertainment and Manufacturing.
- BFSI becomes largest vertical: At 26% of revenues, BFSI is now the biggest vertical, deepened by the PureSoftware acquisition which brought large APAC banking accounts. Healthcare is the third largest and gaining momentum.
- TME momentum from a single large deal: Growth in Media & Entertainment was driven by a discovery exercise and implementation start for one of the largest cinema chains in Mexico and globally, with momentum expected to roll into Q2 and Q3. Travel remains negligible.
- Hi-tech vertical soft, flat YoY: Softness persisted for two quarters, partly due to a bad debt incurred from a significant customer. Some networking and tech customers grew and are visible in the top 20.
- Automation revenue rising on cost pressure: Customers are investing in RPA, BPA and low code/no code to accelerate processes like order-to-cash and inventory management, with GenAI pushing automation further.
- India and APAC surge not repeatable: India growth was driven by a Healthcare company and the transition of engagements from US entities; APAC growth came from the PureSoftware acquisition. Management does not expect this elevated level to continue.
Joseph Anantharaju: "If you recall, a year or maybe 1.5 years back, our share of revenues from U.S. was around 75%, which was uncomfortably high, and through organic means and inorganic means, we've been able to diversify."
US Revenue Decline: The Mechanics
- Deliberate geographic diversification: US revenue share was reduced from ~75% to ~60% through both organic shifts and acquisitions, a strategy management explicitly pursued because the concentration was "uncomfortably high."
- Large program ended without renewal: A 1.5-year customer program completed in Q4 was not re-engaged, contributing directly to the sequential US decline.
- Engagements transitioned to India and GCCs: Several engagements previously managed by US entities were moved to India and GCC centers, transferring revenue from US dollars to India and driving India's growth while shrinking North America's reported contribution.
GenAI Business Unit: The Turnaround
- From loss to breakeven in one quarter: The GenAI Business Services unit swung from an operating loss of ~₹2.53 crores to a marginal profit of ₹24 lakhs, with average utilization reaching ~55%.
- Utilization improved sharply: Utilization in the GenAI unit jumped from 34.3% to 40.8%, reflecting pilots scaling into long-term engagements and better demand-aligned resourcing.
- Profitability target set: Management expects the GenAI unit to reach the same profitability levels as the PDES business by end of this fiscal year or early next year.
- Investment intensity remains high: Even at breakeven, the opportunity cost of the GenAI investment is about ₹3 to 3.5 crores, a drag management is willing to carry while the unit scales.
Venkatraman Narayanan: "The investment intensity is high. That's why I highlighted, even though we are at breakeven, if you look at the opportunity costs, it's about ₹3 crores, ₹3.5 crores."
Margins: Resilience & Coming Pressure
- 20-quarter EBITDA streak intact: EBITDA margin held at 21.4% for the 20th consecutive quarter, achieved while investing in the GenAI business unit, a new sales engine, delivery ecosystem, platforms and innovation.
- Operating margin rebounded sequentially: Operating margin at 17.6% grew 19.7% QoQ, swinging back from a temporary dip. Adjusted operating margin, excluding GenAI and new sales engine investments, was an estimated 18.4% to 18.5%.
- Utilization at 9-quarter high: Utilization reached 78.9%, the best in nine quarters, driven by proactive skill assessment, training, and demand-aligned resourcing. Attrition at 18.2% remains a concern needing compensation adjustments.
- Wage hikes to hit Q2: Planned pay increases in Q2 will create cost pressure. Mitigation requires efficiency in established businesses, payback from GenAI and the new sales engine, and some benefit from foreign currency movements.
- DSO rose on acquisition integration: DSO increased by about 3 days due to integrating GAVS systems and billing; unbilled DSO rose 1 day to 7 days. Both are expected to normalize, with a long-term DSO target of 85 to 88 days.
Venkatraman Narayanan: "In sum, efficiency in our established businesses payback start from our new business segments of Generative AI and our new sales engine and some bit of luck or benefit from foreign currency movements will be definitely required to mitigate people cost increases that we'll see in the coming quarters."
People & Hiring Model Shift
- Headcount declined while revenue grew: Headcount fell QoQ and YoY, remaining relatively flat in recent quarters. Management is deliberately diverging from linear headcount-to-revenue growth, using just-in-time hiring and repurposing people from project to project.
- Attrition driven by skill demand: Digital and AI skills are in high market demand, and Happiest Minds' relatively higher percentage of revenue from these areas puts its people "under the scanner" for poaching. Utilization improvement came partly from identifying individuals who could not meet competency levels.
- AI training at scale: 90% coverage achieved on 101 AI courses, with 201 courses now rolling out to a larger set of people.
Product & Platform Bets
- Arttha gaining traction: The unified banking platform is showing encouraging signs of expansion.
- Insurance-in-a-Box expanding geographically: Currently sold to Managing General Agents in Africa, with plans to extend to other geographies. A couple of large insurance prospects are almost at the point of closure.
- Healthcare product on track: A revolutionary Healthcare product built on bioinformatics capabilities is progressing well, with potential launch by Q1 of FY '27.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Double-digit CC revenue growth | Effort to deliver double-digit growth in constant currency | FY26 full year |
| EBITDA margin range | Maintain 20% to 22% | FY26 full year |
| GenAI unit profitability | Reach same profitability levels as PDES business | By end of FY26 or early FY27 |
| Healthcare product launch | Revolutionary product built on bioinformatics | Potential launch by Q1 FY27 |
| DSO normalization | Bring closer to long-term average of 85 to 88 days | Unspecified |
| Wage hike cycle | Planned pay increases for C1 to C6 levels | Q2 FY26 |
| APAC large account scale | Reach $10 million range | By end of FY26 |
Key Metrics
| Metric | Q1 FY26 |
|---|---|
| Revenue (total income) | ₹580 cr, +18.5% YoY |
| Revenue (USD) | $64.4 mn, +2.3% QoQ and +16% YoY |
| Constant currency growth | 17.5% YoY |
| Constant currency growth (QoQ) | 2.3% |
| EBITDA | ₹124 cr, +12.9% QoQ and +6.3% YoY |
| EBITDA margin | 21.4%, within guided range of 20–22% |
| Operating margin | 17.6%, +19.7% QoQ and +5.8% YoY |
| Adjusted operating margin (excl. GenAI and new sales engine investments) | ~18.4–18.5% |
| PAT | ₹57 cr, +68% QoQ and +12% YoY; margin at 9.9% |
| Adjusted EPS | ₹4.55 |
| GenAI Business Services revenue growth | 89.8% YoY and 14.5% QoQ |
| GenAI Business Services operating result | Broke even, swung from a loss of ~₹2.53 cr in Q4 to a marginal profit of ₹24 lakhs |
| Utilization | 78.9%, highest in the last 9 quarters |
| Voluntary attrition | 18.2%, trended upwards |
| Headcount | 6,523, reduction of 109 QoQ; gross additions ~150 |
| Active customers | 285, up from 281 |
| $1 mn+ customers | 59, up from 57 |
| Repeat business | 94% |
| DSO | 91 days, up from ~88; long-term average target 85–88 days |
| ROCE | 23% |
| ROE | 14% |
| BFSI vertical revenue share | 26% of total revenue |